![Quan Anh Vu](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Quan Anh Vu
Directeur Financier/CFO chez
MONOPAR THERAPEUTICS INC.
Fortune : 248 597 $ au 31/08/2026
Profil
Quan Anh Vu is currently CFO, Treasurer, Secretary & CAO at Monopar Therapeutics, Inc. since 2025.
Former roles include Chief Financial, Accounting & Business Officer at Ocugen, Inc. in 2023; Chief Operating & Business Officer at Forum Markets, Inc. from 2021 to 2023; Chief Executive Officer at Baleena Bioscience, Inc. in 2021; Managing Director at Solganick & Co., Inc. from 2019 to 2021; and Vice President at Opiant Pharmaceuticals, Inc. from 2016 to 2019.
Education includes undergraduate studies at the University of California, Los Angeles and graduate studies at Cornell Law School.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
| 30/06/2026 | 2 221 ( 0,03% ) | 248 597 $ | 31/08/2026 |
Postes actifs de Quan Anh Vu
| Sociétés | Poste | Début |
|---|---|---|
| MONOPAR THERAPEUTICS INC. | Directeur Financier/CFO | 03/03/2025 |
Anciens postes connus de Quan Anh Vu
| Sociétés | Poste | Fin |
|---|---|---|
| OCUGEN, INC. | Directeur Financier/CFO | 14/08/2023 |
| FORUM MARKETS, INCORPORATED | Directeur des opérations | 18/01/2023 |
Solganick & Co., Inc.
 Solganick & Co., Inc. Investment Banks/BrokersFinance Provides investment banking services | Corporate Officer/Principal | 01/10/2021 |
Baleena Bioscience, Inc. | Corporate Officer/Principal | 01/10/2021 |
| OPIANT PHARMACEUTICALS, INC. | Corporate Officer/Principal | 01/08/2019 |
Formation de Quan Anh Vu
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
21
Relations au 1er degré
8
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 8 |
|---|---|
Opiant Pharmaceuticals, Inc.
 Opiant Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Operates as a pharmaceutical company that develops medicines for addictions and drug overdose | Health Technology |
University of California, Los Angeles
 University of California, Los Angeles Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Cornell Law School
 Cornell Law School Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Monopar Therapeutics, Inc.
 Monopar Therapeutics, Inc. BiotechnologyHealth Technology Develops drugs for cancer disease | Health Technology |
Ocugen, Inc.
 Ocugen, Inc. Pharmaceuticals: MajorHealth Technology Develops and commercializes gene therapy products | Health Technology |
Solganick & Co., Inc.
Solganick & Co., Inc. Investment Banks/BrokersFinance Provides investment banking services | Finance |
180 Life Sciences Corp.
 180 Life Sciences Corp. Pharmaceuticals: MajorHealth Technology Develops pharmaceuticals for chronic pain and inflammatory diseases | Health Technology |
Baleena Bioscience, Inc. |
